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Abstract
Background: A specialist neurological infectious disease service has been run jointly by the departments of
infectious disease and neurology at the Royal Liverpool University Hospital since 2005. We sought to describe the
referral case mix and outcomes of the first six years of referrals to the service.
Methods: Retrospective service review.
Results: Of 242 adults referred to the service, 231 (95 %) were inpatients. Neurological infections were confirmed in
155 (64 %), indicating a high degree of selection before referral. Viral meningitis (35 cases), bacterial meningitis (33)
and encephalitis (22) accounted for 38 % of referrals and 61 % of confirmed neurological infections. Although an
infrequent diagnosis (n = 19), neurological TB caused the longest admission (median 23, range 5 – 119 days). A
proven or probable microbiological diagnosis was found in 100/155 cases (64.5 %). For the whole cohort, altered
sensorium, older age and longer hospital stay were associated with poor outcome (death or neurological disability);
viral meningitis was associated with good outcome. In multivariate analysis altered sensorium remained significantly
associated with poor outcome, adjusted odds ratio 3.04 (95 % confidence interval 1.28 – 7.22, p = 0.01).
Conclusions: A service of this type provides important specialist care and a focus for training and clinical research
on complex neurological infections.
Background
Neurological infectious diseases cause an estimated
98.4 years lived with disability per 100 000 people
across the globe [1]. Although the majority of this is in
developing countries, there is also considerable disease
burden in Industrialised Nations [2–4], and the
spectrum of patients seen may be changing [5].
In the UK there is often no uniform approach to investi-
gation and management of patients with suspected neuro-
logical infections [6–9]. Several questions around the
provision of care of neurological infections remain. What
is the burden of admissions and length of hospital stay for
neurological infectious diseases in a specialist setting?
What is the case mix of patients seen in the specialist
setting? What are the clinical outcomes? In many British
hospitals, such patients are managed by internal medicine
but in some centres they are cared for by infectious
diseases specialists or neurologists [10]. We established a
combined neurological infectious diseases service in 2005
and this report reviews the activity of the first 5 years of
this specialist service.
Methods
We conducted a retrospective review of patients referred
to the neurological infectious diseases service between
1st Jan 2005 and 31st December 2009.
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The service is run jointly between the Tropical and In-
fectious Disease Unit of the Royal Liverpool University
Hospital (RLUH) and the Walton Centre NHS Foundation
Trust (formerly the Walton Centre for Neurology and
Neurosurgery). A weekly joint ward round by neurologists
and infectious disease physicians is run at the RLUH for
inpatients. The service also runs a specialist outpatient
clinic. The Tropical and Infectious Diseases Unit (TIDU)
currently has responsibility for 32 of the 850 inpatient
beds at the Royal Liverpool University hospital and has
close clinical links with the Liverpool School of Tropical
Medicine and the Institute of Infection and Global Health
of the University of Liverpool. The hospital provides
secondary care to a population of 750 000, and infectious
disease specialist provision is for a wider population of
approximately 2 million across the region, including
approximately 1500 HIV patients. Inpatient beds on the
unit are covered in rotation by four of twelve specialists in
infectious diseases and tropical medicine. Quality of care
within the service is maintained by action arising from a
rolling program of clinical audit of many aspects of patient
care; some audits are hospital wide while others apply only
to the TIDU. The Walton Centre NHS Foundation Trust
is a tertiary care neuroscience centre with 25 full time
equivalent consultant neurologists and 14 consultant
neurosurgeons. The centre provides care for a population
of approximately 3.5 million in a hub and spoke model,
with neurologists from the centre visiting all hospitals in
the region.
In order to identify patients seen by the service we
searched electronic discharge records and clinic letters of
the unit for the following terms: encephalitis, meningitis,
neuro, neurological infection, neurological, neurologist,
CSF; we also reviewed ward admission/discharge books
and personal logs kept by individual physicians involved
in the service.
Patients who were referred between 1st Jan 2005 and
31st December 2009 were included. Data collected were:
age, sex, referral source, length of hospital stay, inpatient
or outpatient consultation, presenting syndrome, final
diagnosis, microbiological aetiology and outcome. Patients
were classified by presenting syndromes (meningism,
altered sensorium, focal central nervous system (CNS)
signs, peripheral neurological signs, seizures, febrile ill-
ness). The patients’ final diagnosis was based on the
results of standard microbiological investigations and
clinical progress (anti-neuronal antibodies were not in-
cluded). Patients were categorised into neurological infec-
tions and other diagnoses. The presenting clinical features
were assessed to see which were predictive of a neuro-
logical infection.
Neurological infections were considered proven, prob-
able, possible and unknown according to the following
criteria [11]:
 Proven: identification of an organism in the
cerebrospinal fluid (CSF) or brain tissue by culture,
microscopy, nucleic acid amplification or antigen test.
 Probable: in a patient with an appropriate
neurological illness, identification of an organism as
above from non-CNS tissue, or identification of a
classically implicated organism by immuno-assay
(e.g. serology, interferon-gamma release assay), or a
well recognised clinical syndrome where diagnostic
tests are not normally applied.
 Possible: clinical diagnosis (e.g. scan appearance
etc.), non-CNS identification of a non-classical
organism, diagnosis by response to treatment.
 Unknown: clinical picture of neurological infection
but causative agent unknown.
Statistical analysis was conducted using R version 2.13.1.
P values of < 0.05 were considered significant. Factors in-
vestigated for association with death in hospital or neuro-
logical sequelae at discharge were: age, diagnosis, HIV
status, altered sensorium at presentation, presence of
fungal or parasitic infection, length of hospital stay. For
analysis, patients were categorised as having either bad
outcome (death or neurological sequelae) or good out-
come (full recovery). Analysis of categorical variables was
done by Fisher’s exact test, continuous variables by linear
regression. Ninety five percent confidence intervals (95 %
CI) were calculated. Variables with a p < 0.1 were included
in multivariate logistic regression models. All patient data
were anonymised and stored securely in accordance with
current information governance guidelines.
Ethics statement
The service review was approved by the clinical audit
working group of the Royal Liverpool and Broadgreen
University Hospitals NHS Trust (ref. 3413–10/11). Formal
research and ethics approval was not necessary for a
review of patients looked after within our own service.
Results
Two hundred and forty two patients were referred to the
service during the study period (Table 1). Neurological
infections were subsequently confirmed in 155 patients
(64 %, 149 inpatients and 6 outpatients) and other diagno-
ses were made in 87 patients. One hundred and thirty four
patients (55.4 %) were male, 57 were HIV positive and 174
were HIV negative (ten patients were not HIV tested).
Two hundred and thirty one patients were first seen as
inpatients and 11 as outpatients. Sixty-nine percent of
referrals were from within the hosting hospitals, 17 %
were from within 10 miles and 14 % were from more than
10 miles away. There was a trend towards fewer referrals
with increasing distance from the service.
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Presenting syndromes
There was a wide spectrum of presenting problems
(Table 2). The classic triad of fever, headache and abnor-
mal neurology (seizures, altered sensorium or focal neuro-
logical signs) was present in only eight patients (all of
whom had confirmed neurological infections). Many
patients had features of meningism and photophobia
without focal neurological signs. Meningism and altered
sensorium were significantly associated with neurological
infections (meningism OR 2.06, 95 % CI 1.09–4.03; altered
sensorium OR 2.68, 95 % CI 1.36–5.53). Headache was
more frequent in patients who went on to have neuro-
logical infection ruled out.
Final diagnoses
Viral meningitis, bacterial meningitis and encephalitis
were the most common diagnoses accounting for 61 % of
all neurological infections and 38 % of all 242 patients in
the study (Fig. 1). Other, non-neurological, infections were
mostly patients with non-specific febrile illness but in-
cluded two cases of non-neurological TB, two of sinusitis,
and one each of legionnaires disease, tonsillitis, Staphylo-
coccus aureus and Proteus spp. bacteraemia. Other non-
infectious conditions included Parkinson’s disease, benign
intracranial hypertension, hypertensive encephalopathy,
transverse myelitis, sarcoidosis, vasculitis and stroke.
The diagnoses made in HIV positive patients were
different to those in the HIV negative patients (Fig. 1); in
particular there were fewer cases of meningitis. Two cases
of cryptococcal meningitis occurred only in HIV positive
patients. Toxoplasmosis, syphilis, seizure disorders, psy-
chiatric diagnoses and unknown diagnoses were all more
common in the HIV positive patients (Fig. 1). All the
patients with suspected TBM had a final diagnosis of
tuberculosis; in addition three other patients had non-
meningitic neurological TB, two had space occupying
lesions (SOL) and one had choroidal TB.
Causative organisms and diagnostic certainty
The organisms implicated in the patients diagnosed with
neurological infection are shown in Table 3. In all, 100 of
155 patients (64.5 %) had a proven or probable microbio-
logical diagnosis. A possible aetiological diagnosis was made
in 20 patients (13 %) and for 34 patients (22 %) the causa-
tive organism was unknown. Bacterial infection was the
most common (58 cases, including tuberculosis), followed
by viral (50 cases) and lastly fungal/parasitic (11 cases).
Outcome
Out of 242 patients, 149 recovered completely, 53 recov-
ered with neurological sequlae and nine died. For 31 pa-
tients their neurological condition was not clear from the
records, though they were alive at hospital discharge. Full
recovery occurred most often after viral meningitis and
Table 1 Characteristics of all patients in this study
Number seen for suspected neurological infectious disease 242
Confirmed neurological infectious disease 138 (57 %)
Neurological complication of an infectious disease 17 (7 %)
No neurological infection or complication 87 (36 %)
Male 134 (55.4 %)
HIV positive 57 (23.6 %)
Median age (years) 39 (IQR 28–52)







Missing data (though alive at discharge) 31
Table 2 Clinical presentation of 242 patients with suspected neurological infectious disease, divided according to confirmed
neurological infection or other diagnosis
Neurological infectious disease (n = 150) Other diagnosis (n = 91) p value
Fever 33 (22 %) 24 (26 %) 0.44
Headache 45 (30 %) 42 (46 %) 0.01
Meningism 53 (35 %) 19 (21 %) 0.02
Altered sensorium 52 (35 %) 15 (16 %) 0.002
Seizures 13 (9 %) 14 (15 %) 0.14
Focal deficit 11 (7 %) 9 (10 %) 0.48
Peripheral nerve lesion 10 (7 %) 9 (10 %) 0.46
Fever + abnormal neurological finding a 23 (15 %) 6 (7 %) 0.06
Headache + abnormal neurological finding a 16 (11 %) 7 (8 %) 0.51
Fever + headache + abnormal neurological finding a 8 (5 %) 0 0.026
Data represent the number of patients for each individual clinical finding, and patients may be counted more than once
a Abnormal neurological finding is any of: altered sensorium, seizures or focal neurological signs. These groupings count each individual patient once only
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least often after encephalitis or neurological TB. Of the
nine patients who died, eight had neurological infections,
comprising TBM (three), toxoplasmosis (two), bacterial
meningitis (one Listeria monocytogenes and one Escheri-
chia coli) and cytomegalovirus (CMV) encephalitis; the
ninth patient was HIV positive and had cerebral lymph-
oma. The median age of patients who died was 49.5 years
(interquartile range (IQR) 28 to 52.25) and the median age
of patients who survived was 41 (IQR 28 to 56).
Factors associated with poor outcome
In patients with confirmed neurological infections, altered
sensorium, age and longer hospital stay were associated
with poor outcome; viral meningitis was associated with
good outcome (Table 4). In a multivariate logistic regres-
sion model only altered sensorium at presentation was sig-
nificantly associated with poor outcome (Table 4). Data on
outcome were missing for 25 patients; sensitivity analysis
showed they could not significantly affect the analysis
unless all of the patients with altered sensorium and miss-
ing data had complete recovery.
Workload of the service
The 241 patients occupied 2841 bed days over a five-year
period, median length of stay in hospital (LOS) was 9 days
(IQR 4 – 20 days) compared with 5 days for other
patients. Thus the 241 patients represented 5.9 % of the
4057 admissions to the TIDU over the 5 years, but
accounted for 8.5 % of all bed days. Median LOS for viral
meningitis was 4 days (IQR 2–6 days), significantly shorter
than for patients with encephalitis (LOS 18 days IQR
13–32 days), bacterial meningitis (LOS 16 days, IQR
9–21 days) and TBM (LOS 23 days, IQR 16–50 days)
(p < 0.0001). Twelve out of 19 patients with TBM
(63 %) were in the 4th quartile of LOS.
Discussion
This study represents the experience of a specialist neuro-
logical infections service in the UK, seeing 242 patients
over five years. We know of few such services; one depart-
ment in North America has reported the features of 116
referrals over a 15 month period [4]. This equates to 1.8
new patients per week as opposed to approximately 1 per
week in our study.
In our previous broader survey of clinical practice in
ten district general hospitals in the region, 385 patients
with suspected neurological infection were seen over a
three months, just over 3 patients per week in each
hospital [10]. In our specialist service neurological infec-
tions were confirmed in 62 % of patients, compared with
11 % in the regional study [10]. These differences are
likely due to the fact that only patients with highly sus-
pected diagnoses are referred by other medical teams to
the specialist service. In common with other case series
of this type, viral meningitis was the most common diag-
nosis in our study.
A minority of patients in this study exhibited the clas-
sic presentation of fever, headache and focal neurological
signs or meningism, yet many had neurological infec-
tions diagnosed. This is consistent with other studies
showing 10 % of all neurological infections and 44 % of
bacterial meningitis cases presenting with the classic
Fig. 1 Final diagnoses made in 242 patients referred with suspected neurological infection. “HIV other” refers to two cases of HIV associated
myelopathy, one case of optic neuropathy, one adverse drug reaction to anti-retroviral therapy, one case of cerebral vasculitis and one with
Guillain Barré syndrome (the presenting syndrome of HIV infection)
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Table 3 Breakdown of microbiological aetiology and certainty of diagnosis
Diagnosis Organism Certainty
Proven Probable Possible
Viral meningitis Total 14 1 2
Herpes simplex virus 2 7 0 0
Enterovirus 5 0 0
Varicella zoster virus 1 0 0
Epstein Barr virus 1 0 0
Mumps virus 0 1 2
Bacterial meningitis Total 23 5 0
Streptococcus pneumoniae 7 4 0
Neisseria meningitidis 8 1 0
Listeria monocytogenes 3 0 0
Pseudomonas aeruginosa 1 0 0
Streptococcus pyogenes 1 0 0
Haemophilus influenzae 1 0 0
Eschericia coli 1 0 0
Mixed 1 0 0
Encephalitis Total 8 6 1
Herpes simplex virus 1 6 0 1
Cytomegalovirus 1 0 0
Human herpes virus 6 1 0 0
Varicella zoster virus 0 1 0
HIV 0 5 0
TBM Mycobacterium tuberculosis 4 2 13
Peripheral neuropathy Total 0 7 0
Herpes simplex virus 1&2 0 2 0
Cytomegalovirus 0 1 0
Varicella zoster virus 0 1 0
Salmonella typhi 0 1 0
HIV 0 3 0
Retinitis Total 4 3 0
Cytomegalovirus 2 3 0
Varicella zoster virus 2 0 0
Cerebral abscess 2 0 0
Aspergillus sp. 1 0 0
Nocardia sp. 1 0 0
Other syndromes
Syphilis Treponema pallidum 0 5 2
Toxoplasmosis Toxoplasma gondii 0 5 0
Cysticercosis Taenia solium 0 1 2
Crytococcal meningitis Cryptococcus neoformans 1 1 0
Lyme disease Borrelia burgdoferi 0 2 0
Optic neuropathy HIV 0 1 0
Myelopathy HIV 0 2 0
Cerebral vasculitis HIV 0 1 0
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features of these conditions [4, 12]. This suggests that
the “classic presentation” of a neurological infection may
not be the rule. Many patients in this study presented
with photophobia and were labelled as having menin-
gism but received final diagnoses other than a neuro-
logical infection. Photophobia is a subjective feature of
meningism that is at risk of being incorrectly labelled.
A definite or probable microbiological diagnosis was
reached in 64.5 % of our patients. This figure is relatively
high compared with other published reports conducted
in a similar setting [2, 3] and is to be expected as the
service sees selected patients for whom the prior prob-
ability of a neurological infection is high. Moreover,
those studies focussed on encephalitis where a definitive
diagnosis is more difficult to reach [2, 3]. A weakness of
our study is that autoimmune encephalopathies were
not tested for, and some cases may have been missed.
Despite the small numbers of deaths in this study, out-
comes compare favourably with those in other reports,
especially considering the referral bias towards more se-
vere cases [12–14]. In our study the association of young
age and short length of stay with good outcome are
likely proxy markers of viral meningitis. Although we
have not specifically addressed this question, several
other studies have suggested that specialist infection ser-
vices raise significant new differential diagnoses [15] and
improve diagnostic efforts [16], and outcome [17]. It is
likely that a service as described here has the potential
to significantly improve outcome.
Fifty seven (23.6 %) of the patients were HIV positive,
with similar median age of 39 (range 25–68) years com-
pared to those without HIV (40, range 17–94). Overall, a
neurological presentation was the first manifestation of
HIV in 12 of these 57 patients, similar to our previous
description of neurological features in 29/176 (16.5 %)
adults at first presentation with HIV [18]. Five patients
with HIV infection had HIV encephalitis/dementia, which
is a recognised seroconversion illness as well as a late
feature of HIV [18, 19]. There were some unusual diagno-
ses in HIV positive patients, including optic atrophy, cere-
bral vasculitis and atypical Guillian-Barré syndrome which
have all been associated with HIV infection [20–22]. Psy-
chiatric problems are common in HIV positive patients,
but neurological infectious diseases are also common and
can have severe consequences [23]. It is therefore not
surprising that the threshold for investigation for CNS
infection in HIV positive patients is low and is prompted
by any change in mental status, resulting in a number of
psychiatric diagnoses in this cohort.
In addition, 7 patients (6 HIV positive) had neurological
syphilis, emphasizing the need to consider testing for
syphilis as well as for HIV in all patients with possible
neurological infection, especially anyone with dementia,
meningitis or uveitis [24].
This study is limited by its retrospective nature and it is
likely that some patients referred to the service have not
been included in this report. Similarly, some patients may
have not been referred to the service but managed by
general physicians. To try and overcome this, we searched
ICD-10 coded discharge data from our institution. Unfor-
tunately these data were not sufficiently accurate for
inclusion in the study. However, the number of episodes
identified was small, making it unlikely that we have
missed enough patients to affect our conclusions.
Only nine deaths occurred in the study cohort, making
it difficult to reach conclusions on the factors predictive of
death. A further weakness of our study is that we did not
collect data on time to treatment, another variable that
can affect outcome of neurological infections [25–28].
Conclusions
This study found that approximately one patient per week
was referred to a specialist neurological infection service.
The patients with confirmed neurological infections alone
accounted for 8.5 % of total bed occupancy on the unit
Table 3 Breakdown of microbiological aetiology and certainty of diagnosis (Continued)
Antiretroviral drug reaction HIV 0 1 0
Stroke, septic embolus Group C Streptococcus 1 0 0
Grand Totals 57 44 20
The table shows data for 121 patients for whom a microbiological diagnosis was confirmed. A further 34 patients were diagnosed as having a neurological
infectious disease, but the causative organism was unknown
Table 4 Odds ratios for risk of poor outcome (death or
neurological sequelae at discharge) inpatients with neurological
infectious diseases
Individual variables OR 95 % CI p value
Altered sensorium 4.66 2.02 – 11.1 < 0.001
Viral meningitis 0.08 0.009 – 0.35 < 0.001
Age 1.04 1.02 – 1.06 < 0.001
Length of stay 1.03 1.01 – 1.05 < 0.001
Multivariate analysis AOR 95 % CI p>value
Altered sensorium 3.04 1.28 – 7.22 0.01
Viral meningitis 0 NA < 0.001
Age 1.02 0.99 – 1.05 0.14
Length of admission 1.01 1 – 1.03 0.08
OR, odds ratio, AOR, adjusted odds ratio
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although they comprised only 5.6 % of admissions. There-
fore, although the numbers of patients are relatively small,
neurological infectious diseases have a disproportionately
high impact on service usage. The overall mortality of
confirmed neurological infections was relatively low at
5 %, with mortality highest in those with altered sensor-
ium. This service also provides a focus for clinical training
and research to improve our understanding of these
relatively uncommon but serious infections.
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